Article
Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and…
Biologics: Targets and Therapy · 2019 · Samsu N, Soeharto S, Rifai M, Rudijanto A
Key facts
| Title | Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats |
|---|---|
| First author | Samsu N, Soeharto S, Rifai M, Rudijanto A |
| Journal | Biologics: Targets and Therapy |
| Published | Aug 30, 2019 |
| DOI | 10.2147/BTT.S214820 |
| Devices mentioned | K040782 |
| Product codes mentioned | GIA, JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1